PetIQ, Inc. (PETQ) Misses Q4 EPS by 23c, Revenues Beat; Offers FY19 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St futures muted as investors monitor US-Iran negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
PetIQ, Inc. Reports Record Fourth Quarter and Full Year 2018 Financial Results
March 11, 2019 4:05 PM EDTFourth Quarter 2018 Net Sales Increased 114% Year-Over-Year to $111.0 Million Full Year 2018 Net Sales of $528.6 Million Provides Full Year 2019 Outlook
EAGLE, Idaho, March 11, 2019 (GLOBE NEWSWIRE) -- PetIQ, Inc. (PetIQ or the Company) (Nasdaq: PETQ), a leading pet medication and wellness company, today reported financial results for the three months and full year ended December 31, 2018.
Fourth Quarter 2018 Highlights Compared to Prior Year Period
Record fourth quarter net sales of $111.0 million, an increase of 114%;Â representing organic net sales growth of 70%Net loss of... More